Cost-effectiveness of homologous recombination defect testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer
A. Alvarez-Secord, J. Barnett, J. Ledermann, B. Peterson, E. Myers, L. HavrileskyVolume:
125
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.ygyno.2011.12.223
File:
PDF, 141 KB
english, 2012